As in previous years, the programme will be of interest to clinical investigators from across the globe to review current research and discuss its implications for HIV management strategies. Although there have been significant advances in treatment, new challenges have now appeared. This Congress has moved into areas beyond treatment to look at prevention and cure. The role of people living with HIV in treatment decisions and self-management will feature and we look forward to perspectives in the programme from the community.
The Scientific Programme will run from Sunday 10 November to Wednesday 13 November 2024. Please see below preliminary topics to be discussed. To view the latest programme please click here.
|
Keynote Lectures |
|
|---|---|
|
HIV Cure: Lessons Learnt and Prospects for the Future Lecture dedicated to Joep Lange and Jacqueline van Tongeren in recognition of their commitment and passion to rid the world of HIV/AIDS Linos Vandekerckhove, Department of Internal Medicine and Pediatrics, HIV Cure Research Center, University Hospital Ghent, Ghent University, Ghent, Belgium |
|
|
Artificial Intelligence and Digital Technologies: Their Role in Future HIV Research, Treatment and Care Alastair C Van Heerden, Center for Community Based Research, Human Sciences Research Council, Pietermaritzburg, South Africa; and SAMRC/Wits Developmental Pathways for Health Research Unit, University of the Witwatersrand, Johannesburg, South Africa |
|
|
PrEP Therapeutic Agents: What’s on the Horizon and Access? HIV Glasgow is honoured to have been chosen by the Royal College of Physicians and Surgeons of Glasgow to present the Lock Lecture as part of the Scientific Programme Linda-Gail Bekker, Desmond Tutu HIV Centre, University of Cape Town, Cape Town, South Africa |
|
Congress scientific sessions will include: |
|
|---|---|
| Stigma in HIV, past, present and future: Stereotyping patients: impact on HIV treatment | |
| Real life implementation of DoxyPeP: now and future | |
| Ethics in trials of HIV cure | |
| Experience in the implementation of long acting: resource constrained and non-resource constrained scenarios | |
| New Treatments and Future Combinations | |
| Clinical case study session | |
| INSTI resistance and testing | |
| Addressing the Needs of Older Patients in HIV Care | |
| Managing Cardiometabolic risk in HIV: the role of old and new drugs | |
| Elimination of HIV Vertical Transmission Across the World | |
| 2024 Guidelines: An update and CV risk recommendations |
We are delighted to be collaborating with the following organisations for HIV Glasgow 2024 programme planning and development:
British HIV Association
Euroguidelines in Central and Eastern Europe (ECEE) Network Group
European AIDS Clinical Society
European AIDS Treatment Group
International AIDS Society
University of Liverpool DDI team
There is also space in the scientific programme for oral papers and hot topics, selected from submitted abstracts.
Further information will be available soon. Please sign-up to our newsletter to receive all Congress alerts.